TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,479
|
6,556
|
2,820 |
Financial expenses |
10
|
1
|
0 |
Earnings before taxes |
149
|
-3
|
137 |
EBITDA |
181
|
24
|
157 |
Total assets |
10,115
|
3,358
|
939 |
Current assets |
10,102
|
3,326
|
910 |
Current liabilities |
9,711
|
3,121
|
691 |
Equity capital |
404
|
237
|
248 |
- share capital |
51
|
47
|
49 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.0%
|
7.1%
|
26.4% |
Turnover per employee |
1,620
|
1,639
|
940 |
Profit as a percentage of turnover |
2.3%
|
0.0%
|
4.9% |
Return on assets (ROA) |
1.6%
|
-0.1%
|
14.6% |
Current ratio |
104.0%
|
106.6%
|
131.7% |
Return on equity (ROE) |
36.9%
|
-1.3%
|
55.2% |
Change turnover |
-542
|
3,821
|
592 |
Change turnover % |
-8%
|
140%
|
27% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
33%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.